So which firms will benefit?
To answer that question, I took a look at the 17 venture-backed companies that have either conducted IPOs since mid May or filed for intended offerings. Here are the investors holding major stakes in the most deals, according to data from Thomson Reuters, publisher of this blog:
- Sequoia Capital is in four deals;
- Bessemer Venture Partners and Greylock Partners are in three deals each;
- New Enterprise Associates, Tenaya Capital, Kleiner Perkins Caufield & Byers, Trident Capital, Accel Partners, JMI Equity can each vouch for two deals;
- Also in two deals are Goldman Sachs and T Rowe Price and Morgan Stanley.
Obviously, this doesn’t mean each firm will make good money. Several of the post Facebook transactions are less exciting than the others. But by in large, with nine of the 12 completed deals trading above their offering prices, money will be made.
Here is a list of the deals: Tesaro, Exa, ServiceNow, Durata Therapeutics, Kayak Software, Palo Alto Networks, e2Open, Hyperion Therapeutics, Globus Medical, Peregrine Semiconductor, Eloqua and Trulia. Again the data comes from Thomson Reuters.
Several companies remain in the wings with offerings on file and in some cases anticipated shortly. They are Lifelock, Workday, Qualys, Intercept Pharmaceuticals and Gigamon.
The four Sequoia companies are ServiceNow, Palo Alto Networks, Trulia and Kayak. All these deals look pretty good so far. Bessemer is in Lifelock, Eloqua and Qualys, and Greylock is in Workday, ServiceNow and Palo Alto Networks.
Several additional observations are worth making. A total of roughly 36 venture firms have invested in the companies. Another 19 or so institutional investors also participated, as have 16 strategic or corporate investors.
Several of the IPOs have done quite well. Palo Alto Networks, ServiceNow, Trulia, Eloqua and Globus Medical are among them. Keep an eye out for Workday, LifeLock and Qualys.
Photo courtesy of Shutterstock.